We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type |
---|---|---|---|
Mgc Diagnostics Corp. | NASDAQ:MGCD | NASDAQ | Common Stock |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
0.00 | 0.00% | 11.03 | 0.01 | 199,999.99 | 0 | 01:00:00 |
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
SCHEDULE 14D-9
(RULE 14d-101)
SOLICITATION/RECOMMENDATION STATEMENT
UNDER SECTION 14(d)(4) OF THE
SECURITIES EXCHANGE ACT OF 1934
MGC DIAGNOSTICS CORPORATION.
(Name of Subject Company)
MGC DIAGNOSTICS CORPORATION.
(Name of Person(s) Filing Statement)
Common Stock
(Title of Class of Securities)
552768103
(CUSIP Number of Class of Securities)
Todd Austin
Chief Executive Officer
MGC Diagnostics Corporation
350 Oak Grove Parkway
Saint Paul, Minnesota 55127-8599
651-484-4874
(Name, address and telephone number of person
authorized to receive
notices and communications on behalf of the person(s) filing statement)
With a Copy to:
Thomas G. Lovett, IV, Esq.
Jonathan Levy, Esq.
Lindquist & Vennum.LLP.
2000 IDS Center
80 South 8th Street
Minneapolis, MN 55402
(612) 371-3211
X | Check the box if the filing relates solely to preliminary communications made before the commencement of a tender offer. |
99.1 Press release of MGC Diagnostics Corporation dated November 27, 2017
99.2 MGC Diagnostics Corporation Employee Question & Answer Information Summary (November 27, 2017)
1 Year Mgc Diagnostics Corp. Chart |
1 Month Mgc Diagnostics Corp. Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions